SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
junming120
Lv2
120 积分
2023-09-17 加入
最近求助
最近应助
互助留言
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
7天前
已完结
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial
7天前
已完结
Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC)
28天前
已关闭
TiNivo-2: A phase 3, randomized, controlled, multicenter, open-label study to compare tivozanib in combination with nivolumab to tivozanib monotherapy in subjects with renal cell carcinoma who have progressed following one or two lines of therapy where one line has an immune checkpoint inhibitor
1个月前
已关闭
Final Results from a Prospective Randomized Pilot Trial of Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for the Management of Small Renal Masses (RADSTER)
2个月前
已关闭
A prospective randomized parallel-controlled pilot trial of stereotactic body radiation therapy versus radiofrequency ablation for the management of small renal masses
2个月前
已关闭
Stereotactic body radiotherapy for oligometastases
2个月前
已完结
Oligometastases
2个月前
已完结
Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in Vitro and in Vivo in human renal cell carcinoma xenografts
5个月前
已完结
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
5个月前
已完结
没有进行任何应助
自己找到了【积分已退回】
28天前
自己找到了【积分已退回】
1个月前
太慢了【积分已退回】
2个月前
不找了【积分已退回】
2个月前
感谢
6个月前
速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论